TMCI Treace Medical Concepts: Operating Margin

Corporate emblem and logo of Treace Corp (TMCI)

Treace Medical Concepts (TMCI) leverages its own US-based manufacturing facilities and patent protection to ensure the stable production of hallux valgus correction systems. The operating profit spread visualizes this efficiency, where -24.40 reflects the latest value of the metric. The business foundation is the unique Lapiplasty technology for surgeons, while leadership in the bunion treatment niche is sustained by a trained community of physicians, which offsets pressure from larger competitors.

TMCI: Treace Medical Concepts, Inc. Operating Margin 07/04/2022 - 11/19/2026

Treace Medical Concepts - analytical breakdowns and key metrics (TMCI)

- share price and consensus valuation forecast:
Fundamental company analysis:TMCI, Treace Medical Concepts Inc
Brand item of Treace Corp

Operating margin measures the efficiency of the core business before accounting for financial expenses and taxes. By analyzing the operating margin trend, an investor assesses the company's ability to generate profit from revenue. This metric reflects the difference between income and operating expenses, including logistics. For Treace Medical Concepts (TMCI), the stability of this metric confirms the resilience of demand for the Lapiplasty system. The non-cyclical nature of foot surgery protects the margin from market volatility.

Competitors of Treace Medical Concepts (TMCI)

BSX (Boston Scientific Corporation Inc.) - Operating Margin|Operating Margin Edwards Lifesciences Inc.|Operating Margin RMD|Operating Sales Margin Insulet Corporation PODD|Operating Profitability Zimmer Biomet ZBH|CooperVision - Operating Profitability|ALGN - Operating Profitability|GMED: Operating Profitability|TMDX (TransMedics Corp) - Operating Sales Margin|Alphatec Holdings, Inc. - Operating Profit Rate|AORT (Artivion Corp) - Operating Margin|Operating Return on Sales Enovis Corp ENOV|Operating Profitability Integra LifeSciences Corp (IART)|Establishment Labs (ESTA) - Operating Profitability Margin|iLet Bionic Pancreas - Operating Sales Margin|Operating Margin IRADIMED CORPORATION IRMD|Embecta Corp - Operating Margin|Profitability of Operations Tandem Diabetes Care Inc TNDM|Axogen (AXGN) - Operating Profitability|Operating Profit Margin SIBN (SI-BONE Medical)|Operating Profitability orthofix.com|Operating Return on Sales bioventus.com BVS|Operating Margin KIDS|SRTA - Operating Return on Sales|Operating Profitability Carlsmed Inc CARL|RXST: Return on Sales by Operating Profit|CLPT: Operating Sales Margin|stereotaxis.com - Operating Profit Ratio|NeuroStar (STIM) - Operating Profitability|SGHT - Profitability of Operations|Operating Profitability Orchestra BioMed|Return on Sales by Operating Profit ANIK (Anika Therapeutics)|Operating Profitability inspiremd.com (NSPR)|Jin Medical International Ltd - Return on Sales by Operating Profit|Operating Margin VANI (Vivani Medical Inc)|XTNT: Return on Sales by Operating Profit|NMTC - Operating Profitability|MODD: Operating Profitability|MYO: Operating Margin|envoymedical.com - Operating Profit Rate|Operating Sales Margin VVOS|Operating Return on Sales enVVeno NVNO|Operating Margin SINT|TNON - Operating Return on Sales|Operating Profitability ReWalk Robotics LFWD|AMIX: Return on Sales by Operating Profit|IVF - Operating Profitability|Operating Return on Sales Bone Biologics Corp|AXNX: Operating Margin|Operating Sales Margin BIOLASE, Inc.|Operating Sales Margin DYNT|Operating Sales Margin Paragon 28 (FNA)|Operating Profitability INVO Bio (INVO)